Designates first full week of May of each year as "Tardive Dyskinesia Awareness Week" in NJ.

AJR 120 designates the first full week of May each year as "Tardive Dyskinesia Awareness Week" in New Jersey. This resolution directly affects New Jersey residents taking medications that block dopamine (such as antipsychotics for mental illnesses like schizophrenia or bipolar disorder), as these treatments can cause Tardive Dyskinesia (TD) - a condition involving involuntary movements. The bill aims to encourage annual screenings for TD symptoms through public awareness, noting that approximately 1.1 million adults in New Jersey live with mental illnesses that may involve these medications. It does not create new laws or funding but requests the Governor issue an annual proclamation to promote early diagnosis and treatment.